Myocarditis from COVID-19 booster rare, but risk highest among teen boys, young men | American Heart Association
Myocarditis Reported as Rare Adverse Event from COVID-19 Vaccine
Myocarditis and pericarditis following COVID-19 vaccines - The Melbourne Vaccine Education Centre (MVEC)
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ...
As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise? | tctmd.com
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature | BMJ Open
Israel reports very few myocarditis cases among 12-15 year olds after booster | Reuters
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy | BMC Infectious Diseases | Full Text
Myocarditis With COVID-19 mRNA Vaccines | Circulation
Woman died of myocarditis that was likely linked to COVID-19 vaccine booster she received 4 days earlier: Coroner - CNA
Fall boosters, myocarditis, and benefits/risks for young people
ESC 365 - Myocardial Inflammation/Myocarditis After COVID-19 mRNA Booster Vaccination.
Men aged 12-29 can switch to Pfizer vaccine due to risk of heart inflammation linked to Moderna | NHK WORLD-JAPAN News
RACGP - Vaccine and infection myocarditis risks contrasted
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Heart risks, data gaps fuel debate over COVID-19 boosters for young people | Science | AAAS
Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel | Circulation
Study evaluates risk estimates of myocarditis and pericarditis from mRNA-1273 and BNT162b2 vaccines
Myocarditis, pericarditis incidence low across 10 million doses of mRNA COVID-19 vaccines
Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines | Journal of the American College of Cardiology
ATAGI 2023 booster advice | Australian Government Department of Health and Aged Care
Myocarditis, pericarditis remains rare after COVID-19 booster
Myocarditis: A Rare Occurrence Following COVID-19 Vaccination | University of Utah Health
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM
Myocarditis Associated With COVID-19 Booster Vaccination | Circulation: Cardiovascular Imaging
Myocarditis, pericarditis remains rare after COVID-19 booster
RACGP - TGA releases updated COVID booster safety data
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications — Nuffield Department of Primary Care Health Sciences, University of Oxford
Severe side effects from COVID-19 vaccination are rare : Oregon Health News Blog
